K960092

Substantially Equivalent

SERAQUEST TOXOPLASMA IGG

Applicant: Quest Intl., Inc.
Product code: LGD
Advisory panel: Microbiology
Date received: 1996-01-11
Decision date: 1996-06-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: North Miami, FL, US

Adverse events under product code LGD

product code LGD

Malfunction: 502
Total: 502

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.